A Pharmacokinetic study Of Basti in Humans
Phase 2
- Registration Number
- CTRI/2022/09/045276
- Lead Sponsor
- Dr Kusuma H
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Individuals fit for Basti
Exclusion Criteria
Individuals having GIT disturbance
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Comparing systemic excretion and analysing absorption of Kalka, Kashaya, taila in when given through rectal adminstrationTimepoint: 1year 4months
- Secondary Outcome Measures
Name Time Method Getting concentration of bia marker in urine verses time period graphTimepoint: 1year 4 months